Skip to main content
. 2017 Aug 31;18(9):1883. doi: 10.3390/ijms18091883

Table 2.

Mechanisms of HDACi-induced autophagic cell death.

Molecular Mechanism Additional Mechanism HDACi Cell Type Autophagy Monitoring Ref.
mTOR Inhibition S6rp phosphorylation; increased p21 expression SAHA ESS-1 GFP-LC3; MDC staining; TEM [120,171]
Increase of LC3 expression; activation of ULK-1 complex SAHA MEFs, T98G Glioblastoma p62, LC3-I/-II, ATG3, ATG7 WB; GFP-LC3 [173]
Beclin-1 upregulation SAHA, Butyrate HelaS3 GFP-LC3; AVO; FACS [170,177]
Induction of ER stress response SAHA, OSU-HDAC42 HCC, Hep3B, HepG2 LC3-I/-II WB; GFP-LC3; TEM [178]
ROS accumulation via Cat D, repression of TRX; BECN1 and ATG-7 upregulation. SAHA Jurkat T-leukemia BECN1, Atg5, 7, 12 LC3-I/-II WB; GFP-LC3; AVO; TEM [180]
BECN1 protein upregulation. and p62 downregulation SAHA Gliobastoma stem cells LC3-I/-II, BECN1, p62 WB; AVO; IF, TEM [181]
* CASP and CPN-1 activation; reduced ATG expression MGCD0103 Primary CLL p62, LC3-I/-II, ATG5-12; BECN1 WB; [198]
Increased ATG5 expression Apcidin Salivary MEC LC3-I/-II, p62 WB; AVO [209]
ROS Accumulation CathD upregulation and TRX repression SAHA K562, LAMA 84 CMLL N-acetyl-cysteine, chloroquine [182]
Activation of MAPK proteins: ERK1/2 and JNK; LC3 and ATG12 upregulation FK228 + bortezo-mib Gastric carcinoma (GC) LC3-I/-II, Beclin-1, ATG-12 WB [199]
p38 MAPK switch to apoptosis; ERK activation M-275 HCT116 LC3-I/-II ATG5,7 WB; GFP-LC3; TEM [200]
p21 CIP/WAF1 Upregulation SAHA, H40 PC-3M, HL-60 MDC staining [201]
Downregulation of pERK/NF-κB signaling MRJF4 PC3 LC3-I/-II WB; TEM [202]
NF-κB Hyperacetyl-ation Induction of NF-κB target genes SAHA, MS-275 PC3 Expr. Profiling/ATGs; LC3-I/-II, p62 WB [206]
AIF nucleus Translocation FK228 MRT LC3-I/-II; LC3 IF; TEM [205]
Apoptosome Inactivation Independent of p53; Deletion of Apaf-1/Casp-9 LAQ824, LBH589 Eμ-myc lymphomas LC3-I/-II WB; TEM [207]
FoxO1 Transcription ATG expression; mTOR suppression via SESN3 SAHA, TSA HepG2, HCT116 LC3, p62 WB; GFP-LC3; [12]
DAPK Upregulation LBH589 HCT116 p62 WB; LC3-I/-II WB; LC3 IF; AVO [176]
ATG7 Acetylation * Autophagy interactome acetylation; increased mitochondrial mass and ROS formation SAHA, TSA, LBH589, JQ2 Megakaryo-blastic leukemia GFP-LC3; mCherry-LC3 [11]
ATG Gene Upregulation * Independent of p53 acetylation Tenovin-6 CLL LC3-I/LC3-II, p62 WB; TEM [208]
p53 Acetylation Increased p53-dependent cell cycle arrest and apoptosis Sirtinol MCF-7 LC3-I/-II WB; AVO; MDC staining [203]
p53 activation. by reducing MDM2 expression; cell cycle arrest and apodosis MHY2256 MCF-7 LC3-I/-II BECN1 ATG5, 7 WB; AVO [204]
p53-Deficiency mTOR inhibition SAHA ESS-1 p-mTOR WB; MDC staining, GFP-LC3 [197]

* Leads to inhibition of autophagy; AVO (acidic vesicular organelles).